UA80040C2 - Process for the synthesis of (2s)-indoline-2-carboxylic acid and use thereof in the synthesis of perindopril - Google Patents
Process for the synthesis of (2s)-indoline-2-carboxylic acid and use thereof in the synthesis of perindopril Download PDFInfo
- Publication number
- UA80040C2 UA80040C2 UAA200510564A UAA200510564A UA80040C2 UA 80040 C2 UA80040 C2 UA 80040C2 UA A200510564 A UAA200510564 A UA A200510564A UA A200510564 A UAA200510564 A UA A200510564A UA 80040 C2 UA80040 C2 UA 80040C2
- Authority
- UA
- Ukraine
- Prior art keywords
- formula
- carboxylic acid
- synthesis
- indoline
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract description 17
- 230000015572 biosynthetic process Effects 0.000 title abstract description 15
- 238000003786 synthesis reaction Methods 0.000 title abstract description 15
- 229960002582 perindopril Drugs 0.000 title abstract description 9
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title abstract description 8
- QNRXNRGSOJZINA-QMMMGPOBSA-N (2s)-2,3-dihydro-1h-indole-2-carboxylic acid Chemical compound C1=CC=C2N[C@H](C(=O)O)CC2=C1 QNRXNRGSOJZINA-QMMMGPOBSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 abstract description 12
- 150000003839 salts Chemical class 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 description 23
- 239000000203 mixture Substances 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- QNRXNRGSOJZINA-UHFFFAOYSA-N indoline-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)CC2=C1 QNRXNRGSOJZINA-UHFFFAOYSA-N 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VPSSPAXIFBTOHY-LURJTMIESA-N (2s)-2-amino-4-methylpentan-1-ol Chemical compound CC(C)C[C@H](N)CO VPSSPAXIFBTOHY-LURJTMIESA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- XBWOPGDJMAJJDG-UHFFFAOYSA-N 1-cyclohexylethanamine Chemical compound CC(N)C1CCCCC1 XBWOPGDJMAJJDG-UHFFFAOYSA-N 0.000 description 1
- CHPRFKYDQRKRRK-UHFFFAOYSA-N 2-(methoxymethyl)pyrrolidine Chemical compound COCC1CCCN1 CHPRFKYDQRKRRK-UHFFFAOYSA-N 0.000 description 1
- NWYYWIJOWOLJNR-UHFFFAOYSA-N 2-Amino-3-methyl-1-butanol Chemical compound CC(C)C(N)CO NWYYWIJOWOLJNR-UHFFFAOYSA-N 0.000 description 1
- MWGATWIBSKHFMR-UHFFFAOYSA-N 2-anilinoethanol Chemical compound OCCNC1=CC=CC=C1 MWGATWIBSKHFMR-UHFFFAOYSA-N 0.000 description 1
- VJROPLWGFCORRM-UHFFFAOYSA-N 2-methylbutan-1-amine Chemical compound CCC(C)CN VJROPLWGFCORRM-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- STVVMTBJNDTZBF-VIFPVBQESA-N L-phenylalaninol Chemical compound OC[C@@H](N)CC1=CC=CC=C1 STVVMTBJNDTZBF-VIFPVBQESA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960002221 methylephedrine Drugs 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QPILZZVXGUNELN-UHFFFAOYSA-M sodium;4-amino-5-hydroxynaphthalene-2,7-disulfonate;hydron Chemical compound [Na+].OS(=O)(=O)C1=CC(O)=C2C(N)=CC(S([O-])(=O)=O)=CC2=C1 QPILZZVXGUNELN-UHFFFAOYSA-M 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B55/00—Racemisation; Complete or partial inversion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03290879A EP1348684B1 (fr) | 2003-04-09 | 2003-04-09 | Nouveau procédé de synthèse de l'acide (2S)-indoline-2-carboxilique, et application à la synthèse du perindopril |
PCT/FR2004/000857 WO2004092095A1 (fr) | 2003-04-09 | 2004-04-07 | Nouveau procede de synthese de l'acide (2s)-indoline-2- carboxylique, et application a la synthese du perindopril |
Publications (1)
Publication Number | Publication Date |
---|---|
UA80040C2 true UA80040C2 (en) | 2007-08-10 |
Family
ID=27798985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200510564A UA80040C2 (en) | 2003-04-09 | 2004-07-04 | Process for the synthesis of (2s)-indoline-2-carboxylic acid and use thereof in the synthesis of perindopril |
Country Status (28)
Country | Link |
---|---|
US (2) | US7196204B2 (pt) |
EP (1) | EP1348684B1 (pt) |
JP (1) | JP5111849B2 (pt) |
KR (1) | KR100722079B1 (pt) |
CN (1) | CN100337996C (pt) |
AR (1) | AR043993A1 (pt) |
AT (1) | ATE319668T1 (pt) |
AU (1) | AU2004230294B2 (pt) |
BR (1) | BRPI0409095B1 (pt) |
CA (1) | CA2521877C (pt) |
DE (1) | DE60303904T2 (pt) |
DK (1) | DK1348684T3 (pt) |
EA (1) | EA008929B1 (pt) |
EG (1) | EG24152A (pt) |
ES (1) | ES2260585T3 (pt) |
GE (1) | GEP20074257B (pt) |
HK (1) | HK1086816A1 (pt) |
MA (1) | MA27633A1 (pt) |
MX (1) | MXPA05010398A (pt) |
MY (1) | MY138698A (pt) |
NO (1) | NO334199B1 (pt) |
NZ (1) | NZ542396A (pt) |
PL (1) | PL212544B1 (pt) |
PT (1) | PT1348684E (pt) |
SI (1) | SI1348684T1 (pt) |
UA (1) | UA80040C2 (pt) |
WO (1) | WO2004092095A1 (pt) |
ZA (1) | ZA200507567B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2260585T3 (es) * | 2003-04-09 | 2006-11-01 | Les Laboratoires Servier | Nuevo procedimiento de sintesis del acido (2s)-indolin-2-carboxilico y su aplicacion a la sintesis de perindopril. |
CA2575912C (en) * | 2004-11-22 | 2011-10-11 | Apotex Pharmachem Inc. | Process for the preparation of optically pure indoline-2-carboxylic acid |
CN100391945C (zh) * | 2005-05-31 | 2008-06-04 | 浙江大学 | 一种s-(-)-吲哚啉-2-羧酸的合成方法 |
EP1792896A1 (en) | 2005-12-01 | 2007-06-06 | KRKA, tovarna zdravil, d.d., Novo mesto | Process for the preparation of perindopril and salts thereof |
JP5176452B2 (ja) * | 2007-09-27 | 2013-04-03 | 住友化学株式会社 | 光学活性なテトラヒドロピラニルグリシン化合物の製造方法 |
CN101774960B (zh) * | 2009-12-31 | 2011-08-03 | 安徽美诺华药物化学有限公司 | 一种(2s)-二氢吲哚-2-甲酸的制备方法 |
CN101823993A (zh) * | 2010-03-31 | 2010-09-08 | 安徽世华化工有限公司 | L-八氢吲哚啉-2-甲酸的制备方法 |
CN104672124B (zh) * | 2014-12-31 | 2017-08-22 | 浙江昌明药业有限公司 | 对映体富集的二氢吲哚‑2‑甲酸的合成方法 |
CN112321538A (zh) * | 2020-10-28 | 2021-02-05 | 都创(上海)医药开发有限公司 | 一种合成单胺保护的哌嗪-(r/s)2-甲酸酯的方法 |
CN112375028A (zh) * | 2020-12-14 | 2021-02-19 | 安徽美诺华药物化学有限公司 | 合成(2s)-二氢吲哚-甲酸的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS535134A (en) * | 1976-06-30 | 1978-01-18 | Sumitomo Chem Co Ltd | Racemization of optical active 2-(4)chlorophenyl)-3-methylbutylic acid |
JPS58216147A (ja) * | 1982-06-11 | 1983-12-15 | Banyu Pharmaceut Co Ltd | 光学活性なn−アセチル−3−ヒドロキシ−4−(ヒドロキシメチル)フエニルグリシンのラセミ化方法 |
DE3571969D1 (en) * | 1984-05-30 | 1989-09-07 | Du Pont | Preparation of optically-active alpha-substituted phenylacetic acids |
DE3727411A1 (de) * | 1986-08-19 | 1988-03-24 | Ciba Geigy Ag | Verfahren zur herstellung von 2-indolincarbonsaeure |
JPH0780823B2 (ja) * | 1986-08-26 | 1995-08-30 | 東ソー株式会社 | 光学活性フェニルアラニンのラセミ化方法 |
FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
JP2513001B2 (ja) * | 1988-11-01 | 1996-07-03 | 山川薬品工業株式会社 | 光学活性テトラヒドロフラン−2−カルボン酸のラセミ化方法 |
JP3010694B2 (ja) * | 1990-07-09 | 2000-02-21 | 日産化学工業株式会社 | 2―(3―ベンゾイル)フェニルプロピオン酸のラセミ化法 |
NL9001703A (nl) * | 1990-07-27 | 1992-02-17 | Westspur Investment Ltd | Werkwijze voor de bereiding van s(+)-6-methoxy-alfa-methyl-2-naftaleen-azijnzuur. |
US5220053A (en) * | 1992-01-24 | 1993-06-15 | Ethyl Corporation | Preparation of optically active aliphatic carboxylic acids |
ES2061403B1 (es) * | 1993-04-16 | 1995-06-16 | Medichem Sa | Procedimiento de obtencion del acido d-(-) -3 acetiltio-2- metilpropionico. |
JPH08151344A (ja) * | 1994-09-26 | 1996-06-11 | Nagase & Co Ltd | 2−(3−ベンゾイルフェニル)プロピオン酸の光学分割方法 |
US5677469A (en) * | 1995-05-18 | 1997-10-14 | Sepracor, Inc. | Process for resolving chiral acids with 1-aminoindan-2-ols |
ES2260585T3 (es) * | 2003-04-09 | 2006-11-01 | Les Laboratoires Servier | Nuevo procedimiento de sintesis del acido (2s)-indolin-2-carboxilico y su aplicacion a la sintesis de perindopril. |
-
2003
- 2003-04-09 ES ES03290879T patent/ES2260585T3/es not_active Expired - Lifetime
- 2003-04-09 DE DE60303904T patent/DE60303904T2/de not_active Expired - Lifetime
- 2003-04-09 SI SI200330204T patent/SI1348684T1/sl unknown
- 2003-04-09 EP EP03290879A patent/EP1348684B1/fr not_active Expired - Lifetime
- 2003-04-09 AT AT03290879T patent/ATE319668T1/de active
- 2003-04-09 PT PT03290879T patent/PT1348684E/pt unknown
- 2003-04-09 DK DK03290879T patent/DK1348684T3/da active
-
2004
- 2004-04-07 BR BRPI0409095A patent/BRPI0409095B1/pt not_active IP Right Cessation
- 2004-04-07 PL PL377832A patent/PL212544B1/pl unknown
- 2004-04-07 US US10/552,676 patent/US7196204B2/en not_active Expired - Fee Related
- 2004-04-07 AR ARP040101173A patent/AR043993A1/es not_active Application Discontinuation
- 2004-04-07 CA CA2521877A patent/CA2521877C/fr not_active Expired - Fee Related
- 2004-04-07 NZ NZ542396A patent/NZ542396A/en not_active IP Right Cessation
- 2004-04-07 AU AU2004230294A patent/AU2004230294B2/en not_active Ceased
- 2004-04-07 WO PCT/FR2004/000857 patent/WO2004092095A1/fr active Application Filing
- 2004-04-07 GE GEAP20049046A patent/GEP20074257B/en unknown
- 2004-04-07 JP JP2006500165A patent/JP5111849B2/ja not_active Expired - Fee Related
- 2004-04-07 MX MXPA05010398A patent/MXPA05010398A/es active IP Right Grant
- 2004-04-07 KR KR1020057019123A patent/KR100722079B1/ko not_active IP Right Cessation
- 2004-04-07 ZA ZA200507567A patent/ZA200507567B/xx unknown
- 2004-04-07 CN CNB200480009239XA patent/CN100337996C/zh not_active Expired - Fee Related
- 2004-04-07 EA EA200501557A patent/EA008929B1/ru not_active IP Right Cessation
- 2004-04-08 MY MYPI20041284A patent/MY138698A/en unknown
- 2004-07-04 UA UAA200510564A patent/UA80040C2/uk unknown
-
2005
- 2005-09-19 MA MA28504A patent/MA27633A1/fr unknown
- 2005-10-09 EG EGNA2005000629 patent/EG24152A/xx active
- 2005-11-09 NO NO20055257A patent/NO334199B1/no not_active IP Right Cessation
-
2006
- 2006-06-19 HK HK06106955A patent/HK1086816A1/xx not_active IP Right Cessation
-
2007
- 2007-01-05 US US11/649,980 patent/US7323575B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4770174B2 (ja) | グルタミン酸誘導体及びピログルタミン酸誘導体の製造方法並びに新規製造中間体 | |
KR20060134086A (ko) | 모나틴의 제조방법 | |
US7323575B2 (en) | Process for the synthesis of (2S)-indoline-2-carboxylic acid | |
JP2003292484A (ja) | γ−ヒドロキシアミノ酸誘導体及びモナティン類の製造方法 | |
JP2007537189A (ja) | ペリンドプリルまたはおよびその塩の調製のための方法 | |
JP4377412B2 (ja) | ペリンドプリルおよびその薬学的塩の合成方法 | |
JP3930322B2 (ja) | N−〔(s)−1−カルボキシブチル〕−(s)−アラニンエステルの新規合成方法及びペリンドプリルの合成における適用 | |
EA004265B1 (ru) | Способ синтеза n-[(s)-1-карбоксибутил]-(s)-аланиновых эфиров и применение в синтезе периндоприла | |
JPH01287068A (ja) | 4,4―ジ置換プロリンまたは4―モノ置換デヒドロプロリン誘導体 | |
JP4922152B2 (ja) | フッ素化プロリン誘導体の製造方法 | |
JP4331205B2 (ja) | ペリンドプリルおよびその薬学的に許容され得るその塩の、新規な合成方法 | |
JP2008545006A (ja) | Ace阻害剤の合成方法 | |
ES2240921T3 (es) | Procedimiento de sintesis del acido (2s,3as,7as)-perhidroindol-2-carboxilico y sus esteres y su utilizacion en la sintesis de perindopril. | |
CZ278815B6 (en) | Process for stereo selective synthesis of alkylated oxindole derivatives | |
JP4279871B2 (ja) | (2s,3as,7as)−1−[(s)−アラニル]−オクタヒドロ−1h−インドール−2−カルボン酸誘導体類を合成する新規な方法およびペリンドプリル合成におけるその使用 | |
JPH08295662A (ja) | ケトニトリル誘導体及びヘキセノン誘導体の製造方法 | |
Eriksson et al. | The Formation of a Crystalline Oxazolidin-5-one from (L)-Alanine and its Use as a Chiral Template in the Practical Synthesis of α-Substituted Alanine Esters | |
BE876900A (fr) | Procede de production de pyrrolidine-2-ones a partir de 3-pyrroline-2-ones et de production de 3-pyrroline-2-ones |